← Back to Search

Psoriatic arthritis for Psoriatic Arthritis

N/A
Waitlist Available
Led By Sibel Z Aydin, Prof
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).

Eligible Conditions
  • Psoriatic Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intraarticular synovitis scoring
Secondary study objectives
Assessment of entheses images
Assessment of nail images
Assessment of tendon images
+1 more
Other study objectives
Adverse event

Trial Design

1Treatment groups
Experimental Treatment
Group I: Psoriatic arthritisExperimental Treatment1 Intervention
Age ≥18, Meets the classification for psoriatic arthritis (CASPAR) criteria, Able to provide an informed consent, Having peripheral disease phenotype of PsA, At least one tender and swollen join on the day of US
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~4090

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
572 Previous Clinical Trials
2,788,992 Total Patients Enrolled
University of FloridaOTHER
1,380 Previous Clinical Trials
762,365 Total Patients Enrolled
NovartisIndustry Sponsor
1,624 Previous Clinical Trials
2,723,752 Total Patients Enrolled
2 Trials studying Psoriatic Arthritis
1,030 Patients Enrolled for Psoriatic Arthritis
~11 spots leftby Sep 2025